Carl Zeiss Meditec · ISIN: DE0005313704

Carl Zeiss Meditec grows revenue and earnings in the first nine months of 2024/25

Carl Zeiss Meditec grows revenue and earnings in the first nine months of 2024/25  Significant recovery and further expansion of order entry compared to prior year   JENA, 7 August 2025 Carl Zeiss Meditec generated revenue of €1,600.1m in the first nine months of fiscal year 2024/25 (prior year: €1,486.5m), including the DORC consolidation, c......

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

This news feed is a compilation of company-relevant news from the most popular and widest-reaching newswire services. The feed is updated several times. For market-related publications, we recommend the X-Billboard, the Daily News Digest or our Premium Information Service.
Most recent update: 07.08.2025 | 07:00
07 August 2025 07:00AM
Carl Zeiss Meditec grows revenue and earnings in the first nine months of 2024/25
Carl Zeiss Meditec grows revenue and earnings in the first nine months of 2024/25  Significant recovery and further expansion of order entry compared to prior year   JENA, 7 August 2025 Carl Zeiss Meditec generated revenue of €1,600.1m in the first nine months of fiscal year 2024/25 (prior year: €1,486.5m), including the DORC consolidation, c......
Carl Zeiss Meditec
© EQS Newswire
13 May 2025 07:00AM
Carl Zeiss Meditec achieves revenue growth and stable operating profit in the first six months of 2024/25
Carl Zeiss Meditec achieves revenue growth and stable operating profit in the first six months of 2024/25  Further recovery in order entry compared to prior year   JENA, 13 May 2025 Carl Zeiss Meditec generated revenue of €1,050.5m in the first half of fiscal year 2024/25 (prior year: €947.2m), including the DORC consolidation, corresponding ......
Carl Zeiss Meditec
© EQS Newswire
07 May 2025 03:20PM
Change of President and CEO at Carl Zeiss Meditec AG
Change of President and CEO at Carl Zeiss Meditec AG The President and CEO, Dr. Markus Weber, will step down from the Management Board, of his own accord and on the best of terms, on 31 May 2025. Starting 1 June 2025, the new President and CEO will be Maximilian Foerst, who is currently Head of ZEISS Greater China. Jena, Germany | 7 May 2025 | C......
Carl Zeiss Meditec
© EQS Newswire
07 May 2025 02:36PM
Change of President and CEO at Carl Zeiss Meditec AG
Change of President and CEO at Carl Zeiss Meditec AG   Jena, May 7, 2025 The supervisory board of Carl Zeiss Meditec AG (ISIN: DE0005313704) in today’s meeting has agreed on a change in the Management Board of the company. Dr. Markus Weber, President and CEO of Carl Zeiss Meditec AG since January 1, 2022, will turn over his position to Maxi......
Carl Zeiss Meditec
© EQS Newswire
30 April 2025 03:00PM
ZEISS unveils AI-powered Research Data Platform; collaboration with Boehringer Ingelheim champions the future of personalized eye care
Showcasing the future of ophthalmic research at ARVO 2025: ZEISS Research Data Platform launch - a cloud-based, AI-driven technology solution designed to accelerate discoveries, integrating research and clinical data, and simplifying research workflows.ZEISS's collaboration with Boehringer Ingelheim - championing data-driven, personalized care th...
Carl Zeiss Meditec
© PR Newswire
17 April 2025 03:00PM
ZEISS continues to drive digital era forward in ophthalmology; celebrates 2 million digitally-planned cataract cases in the U.S. alone
Showcasing at ASCRS 2025: More than 2 million cases planned with ZEISS VERACITY Surgery Planner: Growing use of one of the leading digital planning solutions for cataract surgery in the U.S. is a testament to the increased adoption of the ZEISS Cataract Workflow digital solutions by surgeons.ZEISS MEL 90 broadens refractive treatment portfolio: U...
Carl Zeiss Meditec
© PR Newswire
15 April 2025 08:57AM
Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25
Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25   Jena, April 15, 2025 In the second quarter of fiscal year 2024/25 ending March 31, 2025, Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of around EUR 560 million (previous year: EUR 472.1 million), based on preliminary data, an increase of around 19%.......
Carl Zeiss Meditec
© EQS Newswire
27 March 2025 09:00AM
ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
JENA, Germany, March 27, 2025 /CNW/ -- ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has received National Medical Products Administration (NMPA) approval in China, marking a significant milestone in the product's global journey....
Carl Zeiss Meditec
© PR Newswire
27 February 2025 10:38AM
ZEISS VISUMAX 800 with SMILE pro software receives approval in China
ZEISS VISUMAX 800 with SMILE pro software receives approval in China   Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow enhancements.   JENA,(Germany), SHANGHAI, (China), | 27 February 2025 | Carl Zeiss Meditec AG ZEISS Medical Technology announced to......
Carl Zeiss Meditec
© EQS Newswire
12 February 2025 06:58AM
Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25
Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25  Significant recovery in order entry and order backlog   JENA, 12 February 2025 Carl Zeiss Meditec generated revenue of €490.5m in the first three months of fiscal year 2024/25 (prior year: €475.0m), corresponding to growth of +3.2% (adjusted for currency effec......
Carl Zeiss Meditec
© EQS Newswire
13 January 2025 03:00PM
ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with treatment for myopia, hyperopia, and mixed astigmatism. DUBLIN, Calif. and JENA, Germany, Jan. 13, 2025 /CNW/ -- ZEISS Medical Technology announced today that the MEL® 90 received approval from the U.S. Food and Drug Administratio...
Carl Zeiss Meditec
© PR Newswire
11 December 2024 07:00AM
Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved
  Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved  Restrictive investment climate and low consumer confidence impact revenue and earnings performance   JENA, 11 December 2024 Carl Zeiss Meditec generated revenue of €2,066.1m in fiscal year 2023/24 (prior year: €2,089.3m), corres......
Carl Zeiss Meditec
© EQS Newswire
09 October 2024 03:00PM
ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions
  Showcasing at AAO 2024: ZEISS VisioGen offers a cutting-edge, AI-driven solution designed to enhance refractive patient communication and streamline clinic operations.ZEISS Milestone: Celebrating more than 10 million eyes treated with lenticule extraction solutions utilizing ZEISS SMILE and ZEISS SMILE pro.ZEISS marked its 25th year of leadersh...
Carl Zeiss Meditec
© PR Newswire
26 September 2024 03:00PM
ZEISS reinvents lens extraction with the first hand-held ultrasound-free lens removal device, available in the U.S.
The ZEISS MICOR 700 uses the ZEISS NULEX (non-ultrasonic lens extraction) procedure to help surgeons broaden their intraocular working space, minimizing risk to surrounding eye structures and increasing operating room efficiency. DUBLIN, Calif. and JENA, Germany, Sept. 26, 2024 /CNW/ -- ZEISS Medical Technology today announced the broad U.S. dist...
Carl Zeiss Meditec
© PR Newswire
12 September 2024 02:00PM
ZEISS Redefines Disease Management and Treatment within the ZEISS Retina Workflow
Showcasing at EURETINA 2024: ZEISS will highlight new surgical innovations and artificial intelligence (AI) tools for retinal patient care, helping doctors diagnose and treat patients efficiently and effectively:  THE FUTURE OF VITREORETINAL SURGERY: Demonstrating the ZEISS ARTEVO 850 3D digital visualization system, Single-use Lenses for ZEISS...
Carl Zeiss Meditec
© PR Newswire
06 August 2024 07:00AM
Carl Zeiss Meditec closes first nine months of 2023/24 with slight decline in revenue
Carl Zeiss Meditec closes first nine months of 2023/24 with slight decline in revenue  Restrictive investment climate and low consumer confidence impact revenue and earnings performance   JENA, 6 August 2024 Carl Zeiss Meditec generated revenue of around €1,486.5m in the first nine months of fiscal year 2023/24 (prior year: €1,509.6m) corresp......
Carl Zeiss Meditec
© EQS Newswire
17 June 2024 10:09AM
Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business   Jena, June 17, 2024 In the first 8 months of fiscal year (FY) 2023/24 as of May 31, 2024, excluding the contribution from the acquisition of Dutch Ophthalmic Research Center B.V. (DORC), Carl Zeiss Meditec AG (ISIN: DE0005313......
Carl Zeiss Meditec
© EQS Newswire
17 June 2024 10:09AM
Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business   Jena, June 17, 2024 In the first 8 months of fiscal year (FY) 2023/24 as of May 31, 2024, excluding the contribution from the acquisition of Dutch Ophthalmic Research Center B.V. (DORC), Carl Zeiss Meditec AG (ISIN: DE0005313......
Carl Zeiss Meditec
© EQS Newswire
08 May 2024 06:26AM
Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects  Planned reduction of stocks of surgical consumables in the Chinese distribution channel successfully completed JENA, 8 May 2024 Carl Zeiss Meditec generated revenue of around €947.2m in the first six months of fiscal year 2023/24 (prior......
Carl Zeiss Meditec
© EQS Newswire
08 May 2024 06:26AM
Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects  Planned reduction of stocks of surgical consumables in the Chinese distribution channel successfully completed JENA, 8 May 2024 Carl Zeiss Meditec generated revenue of around €947.2m in the first six months of fiscal year 2023/24 (prior......
Carl Zeiss Meditec
© EQS Newswire
09 February 2024 07:00AM
Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24
Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24  Decline in profit due to expected weaker product mix   JENA, 9 February 2024 Carl Zeiss Meditec generated revenue of €475.0m in the first quarter of fiscal year 2023/24 (prior year: €470.3m), corresponding to a growth of +1.0% (adjusted for currency effects: +3.3%)......
Carl Zeiss Meditec
© EQS Newswire
29 January 2024 11:11AM
Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
   Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m Jena, 29 January 2024 The Management Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) has, with the approval of the Supervisory Board today, agreed to launch a share buyback program. Under the share buyback program, own shares will be purchased f......
Carl Zeiss Meditec
© EQS Newswire
11 January 2024 01:00PM
U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS   The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements. DUBLIN, CA (USA) / JENA, Germany | January 11, 2024 | Carl Zeiss Meditec AG ZEISS Medical Technology announced today tha......
Carl Zeiss Meditec
© EQS Newswire

The information service offers company-relevant news from leading newswire services in a compact form for a quick overview. When the detailed view is called up, further information can be accessed if required. The navigation elements in previewer mode allow you to quickly switch to the most frequently visited tool sections. From there, you can access further areas that can be used for your own research and analysis. Tip: The information platform now includes more than 50 mini-apps developed in-house.

AI First: Feel free to test the AI integration that will quickly put you on a par with financial journalists and research houses

Further information

The information presented in this section is secondary publications. The content corresponds to the source information. You can find information on the author of the news item in the detailed information of a publication. News relating to listed companies may have been created due to regulatory publication obligations, due to regular public relations work for PR or marketing reasons or by third parties against the background of investor information.

The combination of information and graphic elements contributes significantly to visual orientation and navigation through complex issues. This makes it easier to grasp, contextualize and process key content. Images, logos and other or comparable graphic and textual elements used on the information portal are used for visual navigation, are part of the original message or have illustrative purposes. All rights to these elements are held by the respective owners of the trademark or image rights. They are used without intent to infringe copyright or intellectual property rights. Image material provided via the distribution networks is treated as part of the original message and processed accordingly.

If you believe that copyright or intellectual property rights have been infringed by the presentation, please contact us immediately to clarify your concerns.